Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes

Journal of Leukocyte Biology

Volumn 93, Issue 1, 2013, Pages 135-143

  Talahalli, Ramaprasad ^a   Zarini, Simona ^c   Tang, Jie ^b   Li, Guangyuan ^b   Murphy, Robert ^c   Kern, Timothy S ^b   Gubitosi Klug, Rose A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

5 lipoxygenase; Inflammation; Transcellular synthesis

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE; LEUKOCYTE ADHERENCE; MALE; MASS SPECTROMETRY; MICROVASCULATURE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SUBUNIT; REGULATORY MECHANISM; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA DEGENERATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CAPILLARIES; DIABETIC RETINOPATHY; LEUKOCYTES; LEUKOTRIENES; MICE; MICE, INBRED C57BL; RETINA; RETINAL DEGENERATION; RETINAL VESSELS; TRANSPLANTATION CHIMERA;

MUS;

EID: 84871998547     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0112025     Document Type: Article

References (54)

1. (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44, 968-983.
2. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287, 2563-2569.
3. (2010) Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes. Prescrire Int. 19, 35-38.
4. Engerman, R. L. (1989) Pathogenesis of diabetic retinopathy. Diabetes 38, 1203-1206.
5. Tang, J., Mohr, S., Du, Y. D., Kern, T. S. (2003) Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr. Eye Res. 27, 7-13.
6. Abu El-Asrar, A. M., Al-Mezaine, H. S. (2010) Advances in the treatment of diabetic retinopathy. Discov. Med. 9, 363-373.
7. Schwartz, S. G., Flynn H. W., Jr., Scott, I. U. (2009) Pharmacotherapy for diabetic retinopathy. Expert Opin. Pharmacother. 10, 1123-1131.
8. Scott, I. U., Danis, R. P., Bressler, S. B., Bressler, N. M., Browning, D. J., Qin, H., Diabetic Retinopathy Clinical Research Network (2009) Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina 29, 613-617.
9. Silva, P. S., Sun, J. K., Aiello, L. P. (2009) Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin. Ophthalmol. 24, 93-99.
10. Subramanian, M.L., Ness, S., Abedi, G., Ahmed, E., Daly, M., Feinberg, E., Bhatia, S., Patel, P., Nguyen, M., Houranieh, A. (2009) Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am. J. Ophthalmol. 148, 875-882.
11. Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S. E., Adamis, A. P. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 158, 147-152.
12. Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., Kern, T. S., Adamis, A. P. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450-1452.
13. Chew, E.Y. (2011) Fatty acids and retinopathy. N. Engl. J. Med. 364, 1970-1971.
14. Cuzzocrea, S., Rossi, A., Mazzon, E., Di Paola, R., Genovese, T., Muia, C., Caputi, A. P., Sautebin, L. (2005) 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration. Lab. Invest. 85, 808-822.
15. Dahlen, S. E. (2006) Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur. J. Pharmacol. 533, 40-56.
16. Letts, L. G., (1987) Leukotrienes: role in cardiovascular physiology. Cardiovasc. Clin. 18, 101-113.
17. Mathis, S., Jala, V. R., Haribabu, B. (2007) Role of leukotriene B4 receptors in rheumatoid arthritis. Autoimmun. Rev. 7, 12-17.
18. Osher, E., Weisinger, G., Limor, R., Tordjman, K., Stern, N. (2006) The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Mol. Cell. Endocrinol. 252, 201-206.
19. Peters-Golden, M. (2008) Expanding roles for leukotrienes in airway inflammation. Curr. Allergy Asthma Rep. 8, 367-373.
20. Gubitosi-Klug, R. A., Talahalli, R., Du, Y., Nadler, J. L., Kern, T. S. (2008) 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 57, 1387-1393.
21. Kern, T.S., (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007, 95103.
22. Zhang, W., Liu, H., Al-Shabrawey, M., Caldwell, R. W., Caldwell, R. B. (2011) Inflammation and diabetic retinal microvascular complications. J. Cardiovasc. Dis. Res. 2, 96-103.
23. Frey, T., Antonetti, D. A. (2011) Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid. Redox Signal. 15, 1271-1284.
24. Chronopoulos, A., Tang, A., Beglova, E., Trackman, P. C., Roy, S. (2010) High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function. Diabetes 59, 3159-3166.
25. Gijon, M. A., Zarini, S., Murphy, R. C. (2007) Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells. J. Lipid Res. 48, 716-725.
26. Murphy, R. C., Gijon, M. A. (2007) Biosynthesis and metabolism of leukotrienes. Biochem. J. 405, 379-395.
27. Samuelsson, B. (2000) The discovery of the leukotrienes. Am. J. Respir. Crit. Care Med. 161, S2-S6.
28. Samuelsson, B. (1991) Arachidonic acid metabolism: role in inflammation. Z. Rheumatol. 50 (Suppl. 1), 3-6.
29. Samuelsson, B. (1997) Some recent advances in leukotriene research. Adv. Exp. Med. Biol. 433, 1-7.
30. Samuelsson, B., Claesson, H. E. (1990) Leukotriene B4: biosynthesis and role in lymphocytes. Adv. Prostaglandin Thromboxane Leukot. Res. 20, 1-13.
31. Samuelsson, B., Funk, C. D. (1989) Enzymes involved in the biosynthesis of leukotriene B4. J. Biol. Chem. 264, 19469-19472.
32. Samuelsson, B., Haeggstrom, J. Z., Wetterholm, A. (1991) Leukotriene biosynthesis. Ann. N. Y. Acad. Sci. 629, 89-99.
33. Bäck, M., Bu, D. X., Bränström, R., Sheikine, Y., Yan, Z. Q., Hansson, G. K. (2005) Leukotriene B4 signaling through NF-_B-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. USA 102, 17501-17506.
34. Qiu, H., Johansson, A. S., Sjöström, M., Wan, M., Schröder, O., Palmblad, J., Haeggström, J. Z. (2006) Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc. Natl. Acad. Sci. USA 103, 6913-6918.
35. Sánchez-Galán, E., Gómez-Hernández, A., Vidal, C., Martín-Ventura, J. L., Blanco-Colio, L. M., Muñoz-García, B., Ortega, L., Egido, J., Tuñón, J. (2009) Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc. Res. 81, 216-225.
36. Xu, S., Lu, H., Lin, J., Chen, Z., Jiang, D. (2010) Regulation of TNFα and IL1β in rheumatoid arthritis synovial fibroblasts by leukotriene B4. Rheumatol. Int. 30, 1183-1189.
37. Talahalli, R., Zarini, S., Sheibani, N., Murphy, R. C., Gubitosi-Klug, R. A. (2010) Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 1699-1708.
38. Schwartzman, M. L., Iserovich, P., Gotlinger, K., Bellner, L., Dunn, M. W., Sartore, M., Grazia Pertile, M., Leonardi, A., Sathe, S., Beaton, A., Trieu, L., Sack, R. (2010) Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes 59, 1780-1788.
39. Du, Y., Miller, C. M., Kern, T. S. (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic. Biol. Med. 35, 1491-1499.
40. Zheng, L., Du, Y., Miller, C., Gubitosi-Klug, R. A., Ball, S., Berkowitz, B. A., Kern, T. S. (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50, 1987-1996.
41. Murphy, R. C., Barkley, R. M., Zemski Berry, K., Hankin, J., Harrison, K., Johnson, C., Krank, J., McAnoy, A., Uhlson, C., Zarini, S. (2005) Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346, 1-42.
42. Kern, T. S., Engerman, R. L. (2001) Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50, 1636-1642.
43. Zheng, L., Szabo, C., Kern, T. S. (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κ B. Diabetes 53, 2960-2967.
44. Hattori, T., Matsubara, A., Taniguchi, K., Ogura, Y. (2010) Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo. Curr. Eye Res. 35, 146-154.
45. Ellis, E. A., Grant, M. B., Murray, F. T., Wachowski, M. B., Guberski, D. L., Kubilis, P. S., Lutty, G. A. (1998) Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic. Biol. Med. 24, 111-120.
46. Kowluru, R. A., Kowluru, V., Xiong, Y., Ho, Y. S. (2006) Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 41, 1191-1196.
47. Banasiak, N. C., Meadows-Oliver, M. (2005) Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis. Pediatr. Nurs. 31, 35-38.
48. Chen, M., Lam, B. K., Kanaoka, Y., Nigrovic, P. A., Audoly, L. P., Austen, K. F., Lee, D. M. (2006) Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203, 837-842.
49. Dahlen, S.E., Haeggstrom, J. Z., Samuelsson, B., Rabe, K. F., Leff, A. R. (2000) Leukotrienes as targets for treatment of asthma and other diseases. Current basic and clinical research. Am. J. Respir. Crit. Care Med. 161, S1.
50. del Giudice, M. M., Pezzulo, A., Capristo, C., Alterio, E., Caggiano, S., de Benedictis, D., Capristo, A. F. (2009) Leukotriene modifiers in the treatment of asthma in children. Ther. Adv. Respir. Dis. 3, 245-251.
51. Di Lorenzo, G., Pacor, M. L., Mansueto, P., Esposito-Pellitteri, M., Ditta, V., Lo Bianco, C., Leto-Barone, M. S., Di Fede, G., Rini, G. B. (2006) Is there a role for antileukotrienes in urticaria? Clin. Exp. Dermatol. 31, 327-334.
52. Sharma, J. N., Mohammed, L. A. (2006) The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Inflammopharmacology 14, 10-16.
53. Li, G., Wang, X., Talahalli, R., Gubitosi-Klug, R. A., and Kern, T. S. (2012) Bone marrow-derived cells play a critical role in the development of early stages of diabetic retinopathy and tactile allodynia in mice. Diabetes, doi: 10.2337/db11-1249 [Epub ahead of print].
54. Patarroyo, M., Prieto, J., Rincon, J., Timonen, T., Lundberg, C., Lindbom, L., Asjö, B., Gahmberg, C. G. (1990) Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol. Rev. 114, 67-108.